Search clinical trials for: Drug: NA-831

Total 254383 results

NeuroActiva, Inc.

Completed

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

Neurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive Disorder

New Zealand
NeuroActiva, Inc.

Unknown

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 (NEUROSIVIR)

Severe Acute Respiratory Syndrome | Covid19 | Corona Virus Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Neurodegeneration | Neuroinflammatory Response | Severe Acute Respiratory Infection | Severe Acute Respiratory Syndrome of Upper Respiratory Tract

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
OBI Pharma, Inc

Completed

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

Metastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric Cancer

Taiwan
Neurocrine Biosciences
Takeda

Terminated

A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

Schizophrenia, Cerebellar Ataxia

United Kingdom
Neurocrine Biosciences
Takeda

Completed

Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia

Friedreich Ataxia

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NATADEX)

Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Infection

United States
STEBA France
STEBA LABORATORIES LTD.

Completed

Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers

Gastroesophageal Reflux | Esophagitis | Duodenal Ulcer | Stomach Ulcer

United States
National Taiwan University Hospital

Recruiting

To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence

Esophageal Cancer

Taiwan
University Health Network, Toronto

Unknown

Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues (Stop)

Chronic Hepatitis B

Canada
Children's Hospital of Philadelphia
Friedreich's Ataxia Research Alliance; Stealth BioTherapeutics Inc.

Active, not recruiting

FRDA Investigator Initiated Study (IIS) With Elamipretide (ELViS-FA)

Friedreich Ataxia

United States
NoNO Inc.
University of Calgary

Completed

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1)

Stroke, Acute

United States, Ireland, Korea, Republic of, Canada, Sweden, Germany, United Kingdom, Australia
STEBA France

Suspended

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

Esophagitis, Reflux

Canada
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants

Healthy

United States
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants

Healthy Volunteers

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers

Healthy
Altor BioScience
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Sepsis | Acute Respiratory Distress Syndrome | Acute Lung Injury

United States
Purdue University
Johns Hopkins University; University of California, San Diego; National Heart... and other collaborators

Terminated

DASH-Sodium Trial in Adolescents (CampDASH)

Blood High Pressure

United States
Altor BioScience
Genentech, Inc.; Tanox

Completed

Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome

Sepsis | Acute Respiratory Distress Syndrome | Acute Lung Injury

United States, Canada
University College, London

Active, not recruiting

Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors (RECONCILE)

Prostate Cancer

United Kingdom
HaEmek Medical Center, Israel
Technion, Israel Institute of Technology

Unknown

Detection of Placenta Accreta Via Exhaled Women Breath

Placenta Accreta, Third Trimester

Israel
University of Manitoba

Unknown

Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease

IBD

Canada
Neurocrine Biosciences
Takeda

Completed

A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants

Healthy Volunteers

United States
Neurocrine Biosciences
Takeda

Completed

Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects

Healthy Volunteers

Japan
Kresge Eye Institute

Suspended

Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein

Fluorescein Angiography

United States
Boehringer Ingelheim

Completed

Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules

Hepatitis C

Japan
Changi General Hospital
National Taiwan University Hospital; Asan Medical Center

Completed

RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses

Pancreatic Diseases | Pancreatic Neoplasm

Singapore
Alexandria University

Not yet recruiting

Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time

Dialysis; Complications

Egypt
University Hospital, Geneva
University of Geneva, Switzerland

Completed

Understanding COVID-19

SARS-CoV-2 Viral Kinetics and Host Immune Responses

Switzerland
King Khalid University

Unknown

Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey

Covid19

Saudi Arabia
Children's Hospital of Philadelphia

Completed

Characterization of Cleft Lip and Palate Conditions in Guatemala

Cleft Lip and Palate | Cleft Palate | Cleft Lip

United States
The University of Hong Kong
Yan Chai Hospital

Completed

A Study on Effects of Acupressure Among the Frail Elderly in the Community Dwellings

Impaired

China
Austin Health

Completed

Endoscopy-related Phone Consultation During the COVID-19 Outbreak

Reflux, Gastroesophageal | Colon Disease | Colon Polyp | Varices, Esophageal

Australia
University Medical Center Groningen

Completed

The Identification of Phenotypes in Patients With Severe Chronic Obstructive Pulmonary Disease (Groningen Severe COPD Cohort)

Severe COPD
Wageningen University
Nexira; Roquette Freres; Netherlands: Ministry of Health, Welfare and Sports; B... and other collaborators

Completed

Microbiota Profiling in IBS (IBSQUtrition)

Irritable Bowel Syndrome | Microbial Colonization | Dietary Habits

Netherlands
Boehringer Ingelheim

Completed

Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male Volunteers

Healthy
Neurocrine Biosciences
Takeda

Completed

Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral Administration

Healthy

United Kingdom
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation

Healthy Volunteers

United States
Boehringer Ingelheim

Completed

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Hepatitis C, Chronic

United States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
Boehringer Ingelheim

Completed

Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects

Healthy
NoNO Inc.
University of British Columbia; University of Toronto; University of Calgary; Genome... and other collaborators

Completed

Field Randomization of Nerinetide (NA-1) Therapy in Early Responders (FRONTIER)

Acute Cerebral Ischemia

Canada
Samsung Medical Center

Not yet recruiting

Genomic Profiling of Pancreatic Cystic Tumors

Pancreatic Cyst

Korea, Republic of
National Taiwan University Hospital
National Taiwan University Hospital Hsin-Chu Branch; National Taiwan University...

Recruiting

Cardiac Amyloidosis in HFpEF

Heart Failure With Preserved Ejection Fraction | Amyloidosis Cardiac

Taiwan
The University of Hong Kong
Yan Chai Hospital

Completed

A Study on Effects of Acupressure Among the Frail Elderly in Residential Care Services for the Elderly

Impaired

China
NoNO Inc.

Withdrawn

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms (ENACT-2)

Subarachnoid Hemorrhage | Ruptured Intracranial Aneurysm

Canada, United States
NoNO Inc.
Arbor Vita Corporation

Completed

Evaluating Neuroprotection in Aneurysm Coiling Therapy (ENACT)

Stroke

United States, Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Improving Care Coordination for Adolescents and Young Adults With Cancer

Cancer

United States
NoNO Inc.
University of Calgary

Completed

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT)

Stroke, Acute

United States, Canada, Singapore, Netherlands, Germany, Switzerland, Australia, Norway, Italy
Assistance Publique - Hôpitaux de Paris
National Conservatory of Arts and Crafts (Cnam) of Paris

Unknown

Stress at Work and Infectious Risk in Patients and Caregivers (STRIPPS)

Fatigue | Stress | Occupational Exposure to Blood | Healthcare-associated Related Infections

France
National Cancer Institute (NCI)

Completed

18F-DCFBC PET/CT in Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States

Search clinical trials for: Drug: NA-831

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations